Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[Iovance Biotherapeutics, Inc. Common Stock](/topic/$iova)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$iova/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/$iova/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -X%  
**1 Month**: XX% +10%  
**6 Months**: XX% +17%  
**1 Year**: XX% +15%  
**1-Year High**: XXX% on 2025-03-19  
**1-Year Low**: XX% on 2024-07-20  

**Most Supportive Themes**
- **Future Growth and Partnerships:** (30%) Analysts are optimistic about Iovance's future growth and partnerships, particularly with the five-year results for Amtagvi.
  
**Most Critical Themes**
- **Financial Performance & Stock Value Decline:** (6%)  Concerns about financial performance and stock value decline are being discussed on social media.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXXXX    | XX% | XXXXXX  | XX% | XXXXX    | X% |
| Reddit  | X        | X%  | X       | X%  | X        | X% |
| YouTube | X        | X%  | X       | X%  | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXX    | XX% | XXXXXX  | XX% | XXXXX    | X% |

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Iovance Biotherapeutics, Inc. Common Stock

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -X%
1 Month: XX% +10%
6 Months: XX% +17%
1 Year: XX% +15%
1-Year High: XXX% on 2025-03-19
1-Year Low: XX% on 2024-07-20

Most Supportive Themes

  • Future Growth and Partnerships: (30%) Analysts are optimistic about Iovance's future growth and partnerships, particularly with the five-year results for Amtagvi.

Most Critical Themes

  • Financial Performance & Stock Value Decline: (6%) Concerns about financial performance and stock value decline are being discussed on social media.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXXXX XX% XXXXXX XX% XXXXX X%
Reddit X X% X X% X X%
YouTube X X% X X% X X%
Total XXXXX XX% XXXXXX XX% XXXXX X%
Iovance Biotherapeutics, Inc. Common Stock (IOVA) Sentiment
/topic/$iova/sentiment